Detection of anthrax toxin by an ultrasensitive immunoassay using europium nanoparticles.

Clinical and Vaccine Immunology : CVI
Shixing TangIndira K Hewlett

Abstract

We developed a europium nanoparticle-based immunoassay (ENIA) for the sensitive detection of anthrax protective antigen (PA). The ENIA exhibited a linear dose-dependent pattern within the detection range of 0.01 to 100 ng/ml and was approximately 100-fold more sensitive than enzyme-linked immunosorbent assay (ELISA). False-positive results were not observed with serum samples from healthy adults, mouse plasma without PA, or plasma samples collected from mice injected with anthrax lethal factor or edema factor alone. For the detection of plasma samples spiked with PA, the detection sensitivities for ENIA and ELISA were 100% (11/11 samples) and 36.4% (4/11 samples), respectively. The assay exhibited a linear but qualitative correlation between the PA injected and the PA detected in murine blood (r=0.97731; P<0.0001). Anthrax PA was also detected in the circulation of mice infected with spores from a toxigenic Sterne-like strain of Bacillus anthracis, but only in the later stages of infection. These results indicate that the universal labeling technology based on europium nanoparticles and its application may provide a rapid and sensitive testing platform for clinical diagnosis and laboratory research.

References

Mar 1, 1984·Analytical Biochemistry·I HemmiläT Lövgren
Mar 29, 2000·Protein Expression and Purification·S Park, S H Leppla
Dec 13, 2000·Luminescence : the Journal of Biological and Chemical Luminescence·H HärmäT Lövgren
Dec 19, 2001·Emerging Infectious Diseases·J A JerniganUNKNOWN Anthrax Bioterrorism Investigation Team
Jan 29, 2003·The Journal of Cell Biology·Laurence AbramiF Gisou van der Goot
Feb 1, 2003·Clinica Chimica Acta; International Journal of Clinical Chemistry·Tero SoukkaTimo Lövgren
Mar 24, 2004·Current Opinion in Microbiology·Mahtab Moayeri, Stephen H Leppla
May 13, 2004·Journal of the American Chemical Society·Jwa-Min NamChad A Mirkin
Apr 14, 2005·Chemical Reviews·Nathaniel L Rosi, Chad A Mirkin
Dec 22, 2005·Infection and Immunity·Andrei P PomerantsevStephen H Leppla
Feb 3, 2006·The Journal of Infectious Diseases·Zhaochun ChenRobert Purcell
Sep 21, 2006·Cellular Microbiology·Haijing HuDaoguo Zhou
Feb 23, 2007·The Biochemical Journal·Benjamin E Turk
Aug 19, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Shixing TangIndira K Hewlett
Aug 29, 2007·Infection and Immunity·Mahtab MoayeriStephen H Leppla

❮ Previous
Next ❯

Citations

May 11, 2011·Analytical and Bioanalytical Chemistry·A K Hagan, T Zuchner
Feb 9, 2010·Analytical Chemistry·Lakshmi N CellaAshok Mulchandani
Mar 17, 2010·The Journal of Infectious Diseases·Shixing Tang, Indira Hewlett
Nov 6, 2013·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Annica Tevell ÅbergMikael Hedeland
Jun 22, 2011·Infection and Immunity·Jeyoun JangGi-eun Rhie
Nov 23, 2011·Infection and Immunity·Inka SastallaMahtab Moayeri
Mar 23, 2012·Sensors·Noelia DasilvaManuel Fuentes
Jan 15, 2014·Omics : a Journal of Integrative Biology·Firas H KobeissyKevin Wang
Feb 12, 2014·Journal of Fluorescence·Noam CohenEran Zahavy
May 21, 2011·Journal of Proteomics·Sandipan RaySanjeeva Srivastava
Jun 19, 2013·Diagnostic Microbiology and Infectious Disease·Neha GhoshAjay Kumar Goel
Dec 24, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Siddhesh B ShindeVandana B Patravale
Apr 20, 2010·Journal of Microbiological Methods·Shilpakala Sainath RaoChintamani D Atreya
Nov 17, 2009·Advanced Drug Delivery Reviews·Charalambos KaittanisJ Manuel Perez
Aug 11, 2015·Biosensors & Bioelectronics·Ritu DasSanjay Upadhyay
Aug 8, 2009·Angewandte Chemie·Chuanbin MaoBinrui Cao
May 20, 2015·Applied Biochemistry and Biotechnology·Joungmok KimMoon-Young Yoon
Jun 24, 2016·Expert Review of Molecular Diagnostics·Lars B LaurentiusMarc D Porter
Mar 13, 2018·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Alex J SpositoIndira Hewlett
Mar 3, 2018·Toxins·Miloslava DuracovaJiri Dresler
Mar 16, 2011·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Anne E BoyerJohn R Barr
Jun 12, 2013·The Analyst·Jianling WangXuemei Wang
Jan 20, 2011·Journal of Biomolecular Screening·Ji Sun ChoiMoon-Young Yoon
Jul 29, 2020·Microorganisms·Jean-Nicolas Tournier, Clémence Rougeaux
Sep 1, 2020·PLoS Pathogens·Saleem AlamehMikhail Martchenko Shilman
Jun 6, 2020·Chemistry : a European Journal·Cyrille CharpentierNiko Hildebrandt
Mar 23, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Johnson ThomasIrena Levitan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.